Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00912275 |
|
Recruitment Status
: Unknown
Verified November 2012 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted
: June 3, 2009
Last Update Posted
: November 16, 2012
|
Sponsor:
National Taiwan University Hospital
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
National Taiwan University Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 2013 |
| Estimated Study Completion Date : | December 2013 |